Study on the Metabolic Reprogramming of Lung Cancer Cells Regulated by Docetaxel Based on Metabolomics

Study on the Metabolic Reprogramming of Lung Cancer Cells Regulated by Docetaxel Based on Metabolomics

Background and objective Docetaxel is a commonly used anti-tumor drug in clinic, especially as the first-line drug for advanced non-small cell lung cancer (NSCLC). However, the molecular mechanism of docetaxel against NSCLC is still unclear. Increasing studies have shown that metabolic reprogramming...

Full description

Bibliographic Details
Main Authors: Haichao SUN, Hailong PIAO, Huan QI, Min YAN, Hongxu LIU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2019-04-01
Series:Chinese Journal of Lung Cancer
Subjects:
Docetaxel
Lung neoplasms
Gas chromatography-mass spectrometry
Metabolomics
Tricarboxylic acid cycle
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.02

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.02

Similar Items